Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  4,724 نتائج ل ""Episodic migraine""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migraine (AURORA)

  • Source: A Phase 2, Randomised, Multicentre, Parallel-Group Treatment, Double-Blind Study to Investigate the Safety and Efficacy of Subcutaneous MEDI0618 in the Reduction of

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Report

A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults (E-BEOND)

  • Source: A Phase III, Randomised, Double-blind, Placebo-controlled, Multicenter, Parallel-group Study With Extension Phase to Evaluate the Efficacy and Safety of Dysport® for the Prevention of

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Report

Study of Oral Atogepant Tablets to Assess Change in Disease Activity in Adult Japanese Participants With Episodic Migraine (Release)

  • Source: A Phase 2/3, Multicenter, Randomized, Double-Blind, Placebo Controlled, Parallel-Group Study With An Active Treatment Extension to Evaluate the Efficacy, Safety, and Tolerability of Oral Atogepant for

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Report

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine (REJOIN)

  • Source: Long-term, Open-label (Dose-blinded), Extension Study of Eptinezumab in Children and Adolescents With Chronic or Episodic Migraine

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Report

Safety and Tolerability Study of Daily Dosing Rimegepant in Episodic Migraine Prevention

  • Source: A Phase 4, Open-label Study to Evaluate the Safety and Tolerability of Daily Dosing of Rimegepant in Episodic Migraine Prevention

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Report

A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine (Kaleidoscope)

  • Source: A Phase 3, Multicenter, 12-Week, Double Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of Atogepant for the Preventive Treatment of Episodic

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Report

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine (REBUILD-1)

  • Source: A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Report

Post-Marketing Study to Assess the Safety and Effectiveness of Oral Atogepant in Korean Adult Participants for the Prevention of Chronic or Episodic Migraine (Atogepant PMSS)

  • Source: Post-marketing Surveillance Study to Evaluate the Safety and Effectiveness of Atogepant for the Prevention of Migraine in Korean Adult Patients

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Report

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

  • Source: A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Episodic Migraine

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
Report

A Study of Eptinezumab in Pediatric Participants With Episodic Migraine (PROSPECT-1)

  • Source: Interventional, Randomised, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous (IV) Eptinezumab in Paediatric Patients (6 to 17 Years) for the

تفاصيل العنوان

اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  4,724 نتائج ل ""Episodic migraine""